1-18 of 18 Books
Khimii͡a︡ i primenenie piperazina
Khimii͡a︡ i primenenie piperazina
By Zh Beĭshekeev
Khimii͡a ėtilenimina
Khimii͡a ėtilenimina
By P. A. Gembit͡skiĭ

Reactions of some 1-arylpiperazines and 1-aryl-4-(2-Hydroxy-3-Methoxypropyl) Piperazines
By Hilda Howell

Syntheses and characterization of some 3, 4, 5-trimethoxyphenylethyl derivatives of piperazine and some related compounds
By Bernard Silverman

Derivatives of piperazine XVI
By Jaime Benjamin Fernandez

Studies of the syntheses of piperazine and pyrazine in vapor phase ...
By C. E. Goulding

A study of n-alkylated cyclohexen-2-ylamines and some related heterocyclic derivatives
By James Monroe Bonnell
Piperajin
Piperajin
By Seihin Hyōka Gijutsu Kiban Kikō
BZP
BZP
By National Drug Intelligence Center (U.S.)
Report of the Attorney-General under the New Zealand Bill of Rights Act 1990 on the Misuse of Drugs (Classification of BZP) Amendment Bill 2007
Report of the Attorney-General under the New Zealand Bill of Rights Act 1990 on the Misuse of Drugs (Classification of BZP) Amendment Bill 2007
By New Zealand. Attorney-General.

Derivatives of piperazine and morpholine I
By Vincent Evans Stewart
The synthesis and preliminary pharmacological screening of some benzoyl diamides of ethylenediamine and piperazine
The synthesis and preliminary pharmacological screening of some benzoyl diamides of ethylenediamine and piperazine
By Richard Eugene Lindgren
Syrup of 'Antepar' citrate brand piperazine citrate
Syrup of 'Antepar' citrate brand piperazine citrate
By Burroughs Wellcome & Co. (U.S.A.). Medical Department
The preparation and reactions of some substituted ethylenimines
The preparation and reactions of some substituted ethylenimines
By Lawrence George Hess
The action of lysidine and piperazine as uric acid solvents
The action of lysidine and piperazine as uric acid solvents
By F. Woodcock Goodbody
Report on the risk assessment of BZP in the framework of the Council decision on new psychoactive substances
Report on the risk assessment of BZP in the framework of the Council decision on new psychoactive substances
By Roumen Sedefov